GRI Bio Regains Compliance with Nasdaq
08. Juli 2024 09:05 ET
|
GRI Bio, Inc.
LA JOLLA, CA, July 08, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell...
Klora Makes Its Debut as a Leader in Gut Health With a New Approach to Achieving Homeostasis
14. März 2022 08:00 ET
|
Klora
MIAMI, March 14, 2022 (GLOBE NEWSWIRE) -- Klora, a consumer health brand centered around the gut-mind-body connection, announced the launch of its first two products: Bloat-Digest and Gut-Renew. The...
DiaMedica Therapeutics Announces Publication of a Paper, “Human Tissue Kallikrein in the Treatment of Acute Ischemic Stroke,” in the Journal Therapeutic Advances in Neurological Disorders
22. Januar 2019 07:45 ET
|
DiaMedica Therapeutics Inc.
MINNEAPOLIS, Jan. 22, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (NASDAQ:DMAC) announces the publication of a paper titled “Human Tissue Kallikrein In The Treatment Of Acute Ischemic...
Elsevier Launches New Stem Cell Book Series
23. Mai 2017 04:00 ET
|
Elsevier, Inc.
CAMBRIDGE, MA--(Marketwired - May 23, 2017) - Elsevier, the information analytics company specializing in science and health, today announced a new book series, Advances in Stem Cells and their...